Evidence map›Paper›PMID 42239783›Full record

ArticleResearch square2026

Brief Report on screening data from a randomized controlled trial of in-hospital buprenorphine initiation strategies.

Abigail Haber, Guillermo Sanchez-Fat, Michele Buonora, Annika Sabado, Megan Ghiroli, Yuting Deng, Laila Khalid, Kristine E Torres-Lockhart, Marilyn Reyes, Kelly S Ramsey and 2 more

Abstract readPreprint
In one paragraph

Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Abigail HaberAlbert Einstein College of Medicine.
Guillermo Sanchez-FatAlbert Einstein College of Medicine.
Michele BuonoraAlbert Einstein College of Medicine.
Annika SabadoAlbert Einstein College of Medicine.
Megan GhiroliAlbert Einstein College of Medicine.
Yuting DengAlbert Einstein College of Medicine.
Laila KhalidAlbert Einstein College of Medicine.
Kristine E Torres-LockhartAlbert Einstein College of Medicine.
Marilyn ReyesAlbert Einstein College of Medicine.
Kelly S RamseyAlbert Einstein College of Medicine.
Joanna L StarrelsAlbert Einstein College of Medicine.
Aaron D FoxAlbert Einstein College of Medicine.

Funding

Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)RM1DA055437 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI ARNSTEN, JULIA H., GABBAY, VILMA · 2021 to 2025
$13.7M
NIDA NIH HHS RM1 DA055437
6 · The paper itself

Abstract

Objectives: Buprenorphine (BUP) is effective for treating opioid use disorder and chronic pain (CP); however, there are missed opportunities for initiation during hospitalization. We conducted a clinical trial of in-hospital BUP initiation strategies and reviewed electronic health record data (EHR) to identify potentially eligible patients for BUP treatment. We present trial screening data to analyze the efficiency of EHR surveillance to identify BUP-eligible patients. Methods: Recruitment occurred between 10/2022 to 10/2024 at two urban teaching hospitals. An automated EHR algorithm generated a daily list of patients with likely opioid misuse or OUD. Preliminary manual review of the EHR algorithm was conducted by staff, who then contacted potentially eligible patients and their physicians before assessing for trial eligibility and BUP treatment. If patients were not assessed, research assistants use pre-specified categories to document reasons why. Results: The algorithm produced 9140 records for screening and 8534 (93%) were excluded based on preliminary manual review. Of 434 potentially eligible patients, only 43 agreed to be assessed for the trial. Of the 43 patients, 29 were eligible and 23 enrolled in the trial and started BUP, yielding a 5% initiation rate among the pool of potentially eligible patients. Conclusions: While the automated EHR algorithm identified patients potentially eligible for BUP, substantial manual review was required. Improving algorithm precision, for example with artificial intelligence applications, could better identify BUP-eligible patients; nonetheless, our experience suggests that patient concerns and potential stigma regarding BUP present as ongoing obstacles to BUP uptake.

Indexed as

addiction treatmentartificial intelligencechronic painopioid use disorder

Identifiers

PMID42239783
PMCPMC13228813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.